Current role
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2026-11-02–present
Menassie Taddese
Board Member
Xeris Biopharma Holdings, Inc. (XERS)Equibles does not estimate personal net worth.
Get an email with a short summary when Xeris Biopharma Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get XERS alertsAbout Menassie Taddese
Menassie Taddese is recorded as Board Member at Xeris Biopharma Holdings, Inc. (XERS) since November 2, 2026. Xeris Biopharma Holdings, Inc. reported in an 8-K filed November 2, 2026 that Menassie Taddese was appointed Class II director, effective November 2, 2026. Xeris Biopharma Holdings, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Xeris Biopharma Holdings, Inc. includes John P. Shannon (CEO and Board Member), John Shannon (CEO, Chairman, COO and Board Member), Marla S. Persky (Chairman) and 7 others.
“Effective as of November 2, 2026 (the “Effective Date”), the Board of Directors (the “Board”) of Xeris Biopharma Holdings, Inc. (the “Company”) increased the size of the Board from eight (8) to nine (9) members, thereby creating a vacancy on the Board, and appointed Menassie Taddese to fill such vacancy.”
Affiliation history
-
Current
2026-11-02–present
Company network
Leadership on record at Xeris Biopharma Holdings, Inc.
- John P. Shannon CEO, Board Member
- John Shannon CEO, Chairman, COO, Board Member
- Marla S. Persky Chairman
- Steven M. Pieper CFO
- Kevin McCulloch COO
- Beth P. Hecht General Counsel
- Dawn Halkuff Board Member
- Jeffrey W. Sherman Board Member
- John H. Johnson Board Member
- John Johnson Board Member